The UK Migraine Drugs Market is diversifying rapidly due to segmentation by drug type, administration route, and patient demographics. Triptans, CGRP inhibitors, analgesics, and combination therapies cater to both chronic and episodic migraine sufferers. Clinical studies and research initiatives are optimizing the efficacy of these drugs while minimizing side effects, resulting in...